Linda Mileshkin

Cancer diagnoses following abnormal cell-free DNA detected via non-invasive prenatal testing: A case series, literature review, and proposed management model

Eryn Dow, Alison Freimund, Kortnye Smith, Rodney J Hicks, Peter Jurcevic, Mark Shackleton, Paul James, Andrew Fellowes, Mark Pertile, George McGillivray, Linda Mileshkin

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors

Kate Webber, Elisa Carolus, Linda Mileshkin, Dirkje Sommeijer, Jessica McAlpine, Sarah Bladgen, Robert L Coleman, Thomas J Herzog, Jalid Sehouli, Sara Nasser, Guelhan Inci, Michael Friedlander

Journal article  |  2019  |  Gynecologic Oncology

OBJECTIVES: Our aim was to investigate the prevalence and potential risk factors for persistent and troublesome physical and psych..

The molecular origin and taxonomy of mucinous ovarian carcinoma

Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, Michael S Anglesio, George Au-Yeung, Maret Bohm, David Dl Bowtell, Alison Brand, Georgia Chenevix-Trench, Michael Christie, Yoke-Eng Chiew, Michael Churchman, Anna DeFazio, Renee Demeo, Rhiannon Dudley, Nicole Fairweather, et al.

Journal article  |  2019  |  Nature Communications

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Romerai D'Amico, Anthony Fyles, Marie-Helene Baron, Ina M Jurgenliemk-Schulz, Henry C Kitchener, Hans W Nijman, Godfrey Wilson, Susan Brooks, Sergio Gribaudo, Diane Provencher, Chantal Hanzen, et al.

Journal article  |  2019  |  The Lancet Oncology

PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and updates serous borderline ovarian tumors

Monica Tang, Rachel L O'Connell, Frederic Amant, Philip Beale, Orla McNally, Katrin M Sjoquist, Peter Grant, Alison Davis, Peter Sykes, Linda Mileshkin, Tania Moujaber, Catherine J Kennedy, Anna deFazio, King Tan, Yoland Antill, Jeffrey Goh, Tony Bonaventura, James Scurry, Michael Friedlander

Journal article  |  2019  |  Gynecologic Oncology

OBJECTIVE: Treatment options are limited for patients with recurrent/metastatic low-grade ovarian cancers (LGOCs) and serous borde..

Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial

Lara Edbrooke, Sanchia Aranda, Catherine L Granger, Christine F McDonald, Mei Krishnasamy, Linda Mileshkin, Ross A Clark, Ian Gordon, Louis Irving, Linda Denehy

Conference Proceedings  |  2019  |  Thorax

Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903

Linda Mileshkin, Richard Edmondson, Rachel L O'Connell, Katrin M Sjoquist, John Andrews, Rema Jyothirmayi, Philip Beale, Tony Bonaventura, Jeffrey Goh, Marcia Hall, Andrew Clamp, John Green, Rosemary Lord, Frederic Amant, Laura Alexander, Karen Carty, James Paul, James Scurry, David Millan, Steven Nottley, et al.

Journal article  |  2019  |  Gynecologic Oncology

CUPISCO study: Molecularly guided therapy versus standard chemotherapy in patients with carcinoma of unknown primary

Christian Britschgi, Alwin Kraemer, Ferran Losa, Laurie M Gay, Damian R Page, Stefan Foser, Tariq I Mughal, Jeffrey S Ross, Giulia Baciarello, Linda R Mileshkin, Stuart Osborne, Holger Moch

Conference Proceedings  |  2019  |  SWISS MEDICAL WEEKLY

Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE Study

Olga Kondrashova, Gwo-Yaw Ho, George Au-Yeung, Leakhena Leas, Tiffany Boughtwood, Kathryn Alsop, Giada Zapparoli, Alexander Dobrovic, Yi-An Ko, Arthur L Hsu, Clare J Love, Sebastian Lunke, Matthew J Wakefield, Orla McNally, Michael Quinn, Sumitra Ananda, Deborah Neesham, Anne Hamilton, Marisa Grossi, Alison Freimund, et al.

Journal article  |  2019  |  JCO Precision Oncology

Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years.

Linda R Mileshkin, Tharani Sivakumaran, Dariush Etemadmoghadam, Richard Tothill, Andrew Fellowes, Stephen B Fox, Lisa Guccione, Alison E Freimund, Anna Defazio, Nicholas Wilcken, Bo Gao, Madhu Sudan Singh, Ian M Collins, Gary Edward Richardson, Christopher B Steer, Mark Andrew Warren, Christos Stelios Karapetis, Cindy Bryant, Penelope Schofield, David Bowtell

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

A phase II clinical trial of ipilimumab/nivolumab combination immunotherapy in patients with rare upper gastrointestinal, neuroendocrine, and gynecological malignancies.

Oliver Klein, Damien Kee, Ben Markman, Rachael Chang Lee, Michael Michael, Linda R Mileshkin, Clare L Scott, Richelle Linklater, Sid Menon, Niall C Tebbutt, Jodie Palmer, Andreas Behren, Jonathan S Cebon

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion

Christopher R McEvoy, Huiling Xu, Kortnye Smith, Dariush Etemadmoghadam, Huei San Leong, David Y Choong, David J Byrne, Amir Iravani, Sophie Beck, Linda Mileshkin, Richard W Tothill, David D Bowtell, Bindi M Bates, Violeta Nastevski, Judy Browning, Anthony H Bell, Chloe Khoo, Jayesh Desai, Andrew P Fellowes, Stephen B Fox, et al.

Journal article  |  2019  |  Journal of Clinical Investigation

The trajectory of patients who die from metastatic prostate cancer: a population-based study

Anna Collins, Vijaya Sundararajan, Jeremy Millar, Jodie Burchell, Brian Le, Mei Krishnasamy, Sue-Anne McLachlan, Peter Hudson, Linda Mileshkin, Jennifer Philip

Journal article  |  2019  |  BJU International

Inhibition of RNA Polymerase I Transcription Activates Targeted DNA Damage Response and Enhances the Efficacy of PARP Inhibitors in High-Grade Serous Ovarian Cancer

Elaine Sanij, Katherine Hannan, Shunfei Yan, Jiachen Xuan, Jessica Ahern, Keefe Chan, Jinbae Son, Olga Kondrashova, Elizabeth Lieschke, Matthew Wakefield, Anna Trigos, Daniel Frank, Sarah Ellis, Carleen Cullinane, Jian Kang, Gretchen Poortinga, Purba Nag, Kum Kum Khanna, Linda Mileshkin, Grant McArthur, et al.

Journal article  |  2019

Abstract High-grade serous ovarian cancer (HGSOC) accounts for the majority of ovarian cancer and has a dismal prognosis. PARP inh..

Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer

Sarah P Blagden, Anne L Hamilton, Linda Mileshkin, Shirley Wong, Agnieszka Michael, Marcia Hall, Jeffrey C Goh, Alla S Lisyanskaya, Michelle DeSilvio, Eleni Frangou, Euan A Stronach, Prashanth Gopalakrishna, Tarek M Meniawy, Hani Gabra

Journal article  |  2019  |  Clinical Cancer Research

A randomised phase II trial to examine feasibility of standardised, early palliative (STEP) care for patients with advanced cancer and their families [ACTRN12617000534381]: a research protocol.

Jennifer Philip, Anna Collins, Brian Le, Vijaya Sundararajan, Caroline Brand, Susan Hanson, Jon Emery, Peter Hudson, Linda Mileshkin, Soula Ganiatsas

Journal article  |  2019  |  Pilot and Feasibility Studies

Background: Current international consensus is that 'early' referral to palliative care services improves cancer patient and famil..

Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative.

Aurélie Auguste, Catherine Genestie, Marco De Bruyn, Julien Adam, Audrey Le Formal, Françoise Drusch, Patricia Pautier, Emma J Crosbie, Helen MacKay, Henry C Kitchener, Melanie Powell, Pamela M Pollock, Linda Mileshkin, Richard J Edmondson, Remi Nout, Hans W Nijman, Carien L Creutzberg, Tjalling Bosse, Alexandra Leary

Journal article  |  2018  |  Modern Pathology

The TransPORTEC consortium previouslclassified high-risk endometrial cancer including poor-risk histologies such as clear cells, i..

Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparib

Michael Friedlander, Catherine Shannon, Jeffrey Goh, Clare Scott, Linda Mileshkin

Journal article  |  2018  |  Asia-Pacific Journal of Clinical Oncology

Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series

Emma L Mitchell, Peter Kar Han Lau, Chloe Khoo, David Liew, Jessica Leung, Bonnia Liu, Adam Rischin, Albert G Frauman, Damien Kee, Kortnye Smith, Benjamin Brady, Danny Rischin, Andrew Gibson, Linda Mileshkin, Oliver Klein, Andrew Weickhardt, Surein Arulananda, Mark Shackleton, Grant McArthur, Andrew Ostor, et al.

Journal article  |  2018  |  European Journal of Cancer

Poor understanding of the diagnosis predicts psychological morbidity in cancer of unknown primary patients

Kamil Wolyniec, Lisa Guccione, Linda Mileshkin, Penelope Schofield

Conference Proceedings  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Development of the optimal care pathway for cancer of unknown primary

Linda Mileshkin, Laura Holliday, Amey Aurangabadkar, David Ball, David Bowtell, Cindy Bryant, Jonathan Clark, Katherine Clark, Anthony Gill, Julie Gottlieb, Laura Kirsten, Sally Lord, Siobhan O'Neill, Richard Osborne, Penelope Schofield, Martin Tattersall, Robert Thomas, Richard Tothill, Claire Vajdic, Desmond Yip, et al.

Conference Proceedings  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

PEARL: A randomised phase 3 trial of early referral to palliative care (PC) for patients with advanced thoracic malignancies

Linda R Mileshkin, Jaclyn Yoong, Anna K Nowak, Jennifer Philip, Brian H Lee, Meera Agar, Jane Phillips, Stephen Goodall, Penelope Schofield, Anna Ugalde, David Ball, David Currow, Ian Stubbin, Jennifer S Temel, Katherine Clark, Paula K Lorgelly, Chris Brown, Annette Tognela, Hannora Jurkovic, Antony Mersiades, et al.

Conference Proceedings  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

New horizons in translational research of cancer of unknown primary

Dariush Etemadamoghadam, Atara Posner, Alexandra Murray, Sean Grimmond, Oliver Hofmann, Penelope Schofield, David Bowtell, Linda Mileshkin, Richard W Tothill

Conference Proceedings  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

EX-MED cancer: A best practice exercise medicine program for people with cancer

Prue Cormie, Mark Trevaskis, Anna Boltong, Christopher Carter, Chris Doran, Jon Emery, Ilana Hornung, Mei Krishnasamy, Linda Mileshkin, Meron Pitcher, Amanda Pomery, Kathy Quade, Narelle Quin, Penelope Sanderson, Katherine Simons, Fiona Tansley, Anya Traill, Eva Zopf

Conference Proceedings  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer

Jeffrey C Goh, Sally Baron-Hay, Tony Bonaventura, Martin Buck, Andrew Dean, Michael Friedlander, Bo Gao, Linda Mileshkin, Martin K Oehler, Christopher Steer, Nguyen Vi, Sandra Goble, Nikolay Grechko, Bradley J Monk, Rebecca S Kristeleit

Conference Proceedings  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Comprehensive profiling and molecularly guided therapy (MGT) for carcinomas of unknown primary (CUP): CUPISCO: A phase II, randomised, multicentre study comparing targeted therapy or immunotherapy with standard platinum-based chemotherapy

A Kraemer, F Losa, LM Gay, DR Page, S Foser, TI Mughal, JS Ross, G Baciarello, LR Mileshkin, S Osborne, H Moch

Conference Proceedings  |  2018  |  ANNALS OF ONCOLOGY

Home-based rehabilitation in inoperable lung cancer: a randomised controlled trial

Lara Edbrooke, Sanchia Aranda, Catherine Granger, Christine Mc Donald, Mei Krishnasamy, Linda Mileshkin, Ross Clark, Ian Gordon, Louis Irving, Linda Denehy

Conference Proceedings  |  2018  |  Physiotherapists

COMPARING THE IMPACT OF DOSE REDUCTIONS/ DELAYS ON OVARIAN CANCER OUTCOMES USING THREE WEEKLY OR DOSE DENSE CARBOPLATIN/ PACLITAXEL REGIMENS IN THE NATIONAL PROSPECTIVE OPAL COHORT

L Mileshkin, T Sivakumaran, P Grant, L Na, M Friedlander, P Webb, G Au-Yeung

Conference Proceedings  |  2018  |  INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Outcomes of Australian patients receiving non-funded anti-PD-1 immune checkpoint inhibitors for non-melanoma cancers

Crescens Tiu, Annie Wong, Alan Herschtal, Linda Mileshkin

Journal article  |  2018  |  Asia-Pacific Journal of Clinical Oncology

Advancing clinical research globally: Cervical cancer research network from Mexico

Bryan J Ager, Dolores Gallardo-Rincon, David Cantu de Leon, Adriana Chavez-Blanco, Linus Chuang, Alfonso Duenas-Gonzalez, Eva Gomez-Garcia, Roberto Jerez, Anuja Jhingran, Mary McCormack, Linda Mileshkin, Carlos Perez-Plasencia, Marie Plante, Andres Poveda, David K Gaffney

Journal article  |  2018  |  Gynecologic Oncology Reports

Australian Ovarian Cancer Assortment Trial-Allocating ovarian cancer patients into clinical trials based on molecular profiling.

Olga Kondrashova, George Au-Yeung, Leakhena Leas, Gwo-Yaw Ho, Sebastian Lunke, Kathryn Alsop, Clare Scott, Anne Hamilton, Sumitra Ananda, Alison Freimund, Michael Quinn, Orla McNally, Nadia Traficante, Tiffany Cowie, Matthew Wakefield, Arthur Hsu, Alex Dobrovic, Michael Christie, Graham Taylor, David Bowtell, et al.

Conference Proceedings  |  2018  |  CLINICAL CANCER RESEARCH

Transition Points for the Routine Integration of Palliative Care in Patients With Advanced Cancer

Anna Collins, Vijaya Sundararajan, Jodie Burchell, Jeremy Millar, Sue-Anne McLachlan, Meinir Krishnasamy, Brian H Le, Linda Mileshkin, Peter Hudson, Jennifer Philip

Journal article  |  2018  |  Journal of Pain and Symptom Management

A Phase 1B Study of the Anti-PD-1 Monoclonal Antibody, Tislelizumab, in Combination with the Parp Inhibitor, Pamiparib, in Advanced Solid Tumors

M Friedlander, T Meniawy, B Markman, LR Mileshkin, P Harnett, M Millward, J Lundy, AE Freimund, C Norris, J Wu, V Paton, L Wang, B Gao

Conference Proceedings  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Alessandro Colombo, Anthony Fyles, Marie-Helene Baron, Ina M Jurgenliemk-Schulz, Henry C Kitchener, Hans W Nijman, Godfrey Wilson, Susan Brooks, Silvestro Carinelli, Diane Provencher, Chantal Hanzen, et al.

Journal article  |  2018  |  The Lancet Oncology

A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.

Michael Friedlander, Tarek Meniawy, Ben Markman, Linda R Mileshkin, Paul Harnett, Michael Millward, Joanne Lundy, Alison E Freimund, Christie Norris, John Wu, Virginia Paton, Lai Wang, Bo Gao

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer

Dale W Garsed, Kathryn Alsop, Sian Fereday, Catherine Emmanuel, Catherine J Kennedy, Dariush Etemadmoghadam, Bo Gao, Val Gebski, Valerie Gares, Elizabeth L Christie, Maartje CA Wouters, Katy Milne, Joshy George, Ann-Marie Patch, Jason Li, Gisela Mir Arnau, Timothy Semple, Sreeja R Gadipally, Yoke-Eng Chiew, Joy Hendley, et al.

Journal article  |  2018  |  Clinical Cancer Research

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

SM de Boer, BG Wortman, T Bosse, ME Powell, N Singh, H Hollema, G Wilson, MN Chowdhury, L Mileshkin, J Pyman, D Katsaros, S Carinelli, A Fyles, CM McLachlin, C Haie-Meder, P Duvillard, RA Nout, KW Verhoeven-Adema, H Putter, CL Creutzberg, et al.

Journal article  |  2018  |  Annals of Oncology

Development of a hospital-based patient-reported outcome framework for lung cancer patients: a study protocol

Natasha Moloczij, Karla Gough, Benjamin Solomon, David Ball, Linda Mileshkin, Mary Duffy, Mei Krishnasamy

Journal article  |  2018  |  Health and Quality of Life Outcomes

Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma

Lavinia Tan, Marliese Alexander, Ann Officer, Michael MacManus, Linda Mileshkin, Ross Jennens, Dishan Herath, Richard de Boer, Stephen B Fox, David Ball, Benjamin Solomon

Journal article  |  2018  |  Internal Medicine Journal

COOPERATIVE GROUPS: THE AUSTRALIAN PERSPECTIVE

Prudence A Francis, Katrin Sjoquist, Linda Mileshkin

Book Chapter  |  2018

Developing a Lung Cancer Clinical Quality Registry Framework to Collect Longitudinal Patient-Reported Outcomes

N Moloczij, M Duffy, K Gough, D Ball, B Solomon, L Mileshkin, M Krishnasamy

Conference Proceedings  |  2017  |  Journal of Thoracic Oncology

Patterns of practice survey for brachytherapy for cervix cancer in Australia and New Zealand

Karen Lim, Sylvia van Dyk, Pearly Khaw, Jacqueline Veera, Linda Mileshkin, Lucy Ohanessian, Michelle Harrison, Shalini K Vinod

Journal article  |  2017  |  Journal of Medical Imaging and Radiation Oncology

Benefits of home-based multidisciplinary exercise and supportive care in inoperable non-small cell lung cancer - protocol for a phase II randomised controlled trial

Lara Edbrooke, Sanchia Aranda, Catherine L Granger, Christine F McDonald, Mei Krishnasamy, Linda Mileshkin, Louis Irving, Sabine Braat, Ross A Clark, Ian Gordon, Linda Denehy

Journal article  |  2017  |  BMC Cancer

Differences in experiences of care between patients diagnosed with metastatic cancer of known and unknown primaries: mixed-method findings from the 2013 cancer patient experience survey in England

Richard Wagland, Mike Bracher, Allison Drosdowsky, Alison Richardson, John Symons, Linda Mileshkin, Penny Schofield

Journal article  |  2017  |  BMJ Open

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.

RJ Edmondson, EJ Crosbie, M Nickkho-Amiry, A Kaufmann, E Stelloo, HW Nijman, A Leary, A Auguste, L Mileshkin, P Pollock, HJ MacKay, ME Powell, T Bosse, CL Creutzberg, HC Kitchener

Journal article  |  2017  |  Gynecologic Oncology

BACKGROUND: The morphological classification of high-risk endometrial cancer is of limited prognostic value. Recent attempts to st..

Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia

Yeh Chen Lee, Rene Kroon, Bogda Koczwara, Ian Haines, Kay Francis, Michael Millward, Richard Kefford, Ian Olver, Linda Mileshkin

Journal article  |  2017  |  Internal Medicine Journal

Cervical Cancer: A Global Health Crisis

William Small, Monica A Bacon, Amishi Bajaj, Linus T Chuang, Brandon J Fisher, Matthew M Harkenrider, Anuja Jhingran, Henry C Kitchener, Linda R Mileshkin, Akila N Viswanathan, David K Gaffney

Journal article  |  2017  |  Cancer

Discussing and prescribing expensive unfunded anticancer drugs in Australia

Deme John Karikios, Linda Mileshkin, Andrew Martin, Danielle Ferraro, Martin R Stockler

Journal article  |  2017  |  ESMO Open

Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer

Anthony Bonaventura, Rachel L O'Connell, Cristina Mapagu, Philip J Beale, Orla M McNally, Linda R Mileshkin, Peter T Grant, Alison M Hadley, Jeffery CH Goh, Katrin M Sjoquist, Julie Martyn, Anna DeFazio, James Scurry, Michael L Friedlander

Journal article  |  2017  |  International Journal of Gynecological Cancer

A phase II trial of durvalumab (Medi 4736) in advanced endometrial cancer: PHAEDRA.

Yoland Catherine Antill, Martin R Stockier, Peey Sei Kok, Kristy Pamela Robledo, Kim Gillies, John Stark, Sonia Yip, Linda R Mileshkin

Conference Proceedings  |  2017  |  Journal of Clinical Oncology

Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer

Stephanie M de Boer, Melanie E Powell, Linda R Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Alessandro Colombo, Anthony W Fyles, Marie-Helene Baron, Henry C Kitchener, Hans Nijman, Roy FPM Kruitwagen, Ina M Jurgenliemk-Schulz, Remi A Nout, Vincent THBM Smit, Hein Putter, Carien L Creutzberg

Conference Proceedings  |  2017  |  Journal of Clinical Oncology

A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.

Michael Friedlander, Tarek Meniawy, Ben Markman, Linda R Mileshkin, Paul R Harnett, Michael Millward, Joanne Lundy, Alison E Freimund, Christie Norris, Song Mu, John Wu, Virginia E Paton, Lai Wang, Bo Gao

Conference Proceedings  |  2017  |  Journal of Clinical Oncology

Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists

Christos S Karapetis, Lisa Guccione, Martin HN Tattersall, Helen Gooden, Claire M Vajdic, Sylvie Lambert, Monica Robotin, Linda Mileshkin, Penelope Schofield

Journal article  |  2017  |  Internal Medicine Journal

Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition

George Au-Yeung, Franziska Lang, Walid J Azar, Chris Mitchell, Kate E Jarman, Kurt Lackovic, Diar Aziz, Carleen Cullinane, Richard B Pearson, Linda Mileshkin, Danny Rischin, Alison M Karst, Ronny Drapkin, Dariush Etemadmoghadam, David DL Bowtell

Journal article  |  2017  |  Clinical Cancer Research

Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation

Yada Kanjanapan, Siddhartha Deb, Richard J Young, Mathias Bressel, Linda Mileshkin, Danny Rischin, Michael S Hofman, Kailash Narayan, Shankar Siva

Journal article  |  2017  |  Clinical and Translational Radiation Oncology

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Florine AA Eggink, Inge CB Van Gool, Alexandra C Leary, Pamela MD Pollock, Emma JE Crosbie, Linda F Mileshkin, Ekaterina S bg Jordanova, Julien C Adam, Luke H Freeman-Mills, David N hi Church, Carien LJ Creutzberg, Marco A De Bruyn, Hans WA Nijman, Tjalling B Bosse

Journal article  |  2017  |  OncoImmunology

Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum-sensitive recurrent ovarian cancer

Michael Friedlander, Susana Banerjee, Linda Mileshkin, Clare Scott, Catherine Shannon, Jeffrey Goh

Journal article  |  2016  |  Asia-Pacific Journal of Clinical Oncology

Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial

Prunella Blinman, Linda Mileshkin, Pearly Khaw, Geraldine Goss, Carol Johnson, Anne Capp, Susan Brooks, Gerard Wain, Ilka Kolodziej, Anne-Sophie Veillard, Rachel O'Connell, Carien L Creutzberg, Martin R Stockler

Journal article  |  2016  |  British Journal of Cancer

Improvement of Outcomes for Women With HIV Infection and Cervical Cancer

Linda R Mileshkin, Alison E Freimund

Journal article  |  2016  |  Journal of Clinical Oncology

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

Sebastian Moran, Anna Martinez-Cardus, Sergi Sayols, Eva Musulen, Carme Balana, Anna Estival-Gonzalez, Catia Moutinho, Holger Heyn, Angel Diaz-Lagares, Manuel Castro de Moura, Giulia M Stella, Paolo M Comoglio, Maria Ruiz-Miro, Xavier Matias-Guiu, Roberto Pazo-Cid, Antonio Anton, Rafael Lopez-Lopez, Gemma Soler, Federico Longo, Isabel Guerra, et al.

Journal article  |  2016  |  The Lancet Oncology

Continuing variation and barriers to nurse-led vaginal dilator education for women with gynaecological cancer receiving radiotherapy

Rebecca Bergin, Alison Hocking, Taryn Robinson, Donna Kabel, Linda Mileshkin, Ilona Juraskova, David Bernshaw, Sanchia Aranda, Penelope Schofield

Journal article  |  2016  |  European Journal of Oncology Nursing

A community-based model of rapid autopsy in end-stage cancer patients

Kathryn Alsop, Heather Thorne, Shahneen Sandhu, Anne Hamilton, Christopher Mintoff, Elizabeth Christie, Odette Spruyt, Scott Williams, Orla McNally, Linda Mileshkin, Sumitra Ananda, Julene Hallo, Sherene Loi, Clare Scott, Peter Savas, Lisa Devereux, Patricia O'Brien, Sameera Gunawardena, Clare Hampson, Kate Strachan, et al.

Journal article  |  2016  |  Nature Biotechnology

A smoking cessation programme for current and recent ex-smokers following diagnosis of a potentially curable cancer

J Ong, I Plueckhahn, D Cruickshank, L Churilov, L Mileshkin

Journal article  |  2016  |  Internal Medicine Journal

Impact of a specialist clinical cancer pharmacist at a multidisciplinary lung cancer clinic

Clare Walter, James D Mellor, Carol Rice, Sue Kirsa, David Ball, Mary Duffy, Alan Herschtal, Linda Mileshkin

Journal article  |  2016  |  Asia-Pacific Journal of Clinical Oncology

Results of the Australasian (Trans-Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC-3 trial

Michael G Jameson, Jo McNamara, Michael Bailey, Peter E Metcalfe, Lois C Holloway, Kerwyn Foo, Viet Do, Linda Mileshkin, Carien L Creutzberg, Pearly Khaw

Journal article  |  2016  |  Journal of Medical Imaging and Radiation Oncology

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Alessandro Colombo, Anthony Fyles, Marie-Helene Baron, Henry C Kitchener, Hans W Nijman, Roy F Kruitwagen, Remi A Nout, Karen W Verhoeven-Adema, Vincent T Smit, Hein Putter, Carien L Creutzberg

Journal article  |  2016  |  The Lancet Oncology

PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer

J Martyn, F Roncolato, ML Willson, K Lindemann, L Mileshkin

Journal article  |  2016  |  Cochrane Database of Systematic Reviews

Oral cyclophosphamide in recurrent ovarian cancer

Despina Handolias, Michael Quinn, Serene Foo, Linda Mileshkin, Peter Grant, Gaelle Dutu, Danny Rischin

Journal article  |  2016  |  Asia-Pacific Journal of Clinical Oncology

Developing an Evidence-Based, Nurse-Led Psychoeducational Intervention With Peer Support in Gynecologic Oncology

Rebecca J Bergin, Suzi M Grogan, David Bernshaw, Ilona Juraskova, Sylvia Penberthy, Linda R Mileshkin, Meinir Krishnasamy, Alison C Hocking, Sanchia K Aranda, Penelope E Schofield

Journal article  |  2016  |  Cancer Nursing

Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer

Inge C Van Gool, Ellen Stelloo, Remi A Nout, Hans W Nijman, Richard J Edmondson, David N Church, Helen J MacKay, Alexandra Leary, Melanie E Powell, Linda Mileshkin, Carien L Creutzberg, Vincent THBM Smit, Tjalling Bosse

Journal article  |  2016  |  Modern Pathology

Advances and Concepts in Cervical Cancer Trials A Road Map for the Future

Satoru Sagae, Bradley J Monk, Eric Pujade-Lauraine, David K Gaffney, Kailash Narayan, Sang Young Ryu, Mary McCormack, Marie Plante, Antonio Casado, Alexander Reuss, Adriana Chavez-Blanco, Henry Kitchener, Byung-Ho Nam, Anuja Jhingran, Sarah Temkin, Linda Mileshkin, Els Berns, Suzy Scholl, Corinne Doll, Nadeem R Abu-Rustum, et al.

Journal article  |  2016  |  International Journal of Gynecological Cancer

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial.

HJ Gray, B Benigno, J Berek, J Chang, J Mason, L Mileshkin, P Mitchell, M Moradi, FO Recio, CM Michener, A Alvarez Secord, NE Tchabo, JK Chan, J Young, H Kohrt, SE Gargosky, JC Goh

Journal article  |  2016  |  Journal for ImmunoTherapy of Cancer

BACKGROUND: CAN-003 was a randomized, open-label, Phase 2 trial evaluating the safety, efficacy and immune outcomes of CVac, a muc..

F-18-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data

Shankar Siva, Siddhartha Deb, Richard J Young, Rodney J Hicks, Jason Callahan, Mathias Bressel, Linda Mileshkin, Danny Rischin, David Bernshaw, Kailash Narayan

Journal article  |  2015  |  European Journal of Nuclear Medicine and Molecular Imaging

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters

MA Versluis, RA de Jong, A Plat, T Bosse, VT Smit, H Mackay, M Powell, A Leary, L Mileshkin, HC Kitchener, EJ Crosbie, RJ Edmondson, CL Creutzberg, H Hollema, T Daemen, GH de Bock, HW Nijman

Journal article  |  2015  |  British Journal of Cancer

Weighing up the benefits and harms of a new anti-cancer drug: a survey of Australian oncologists

L Chim, G Salkeld, MR Stockler, L Mileshkin

Journal article  |  2015  |  Internal Medicine Journal

Differential kinetics of response and toxicity using stereotactic radiation and interventional radiological coiling for pulmonary arterio-venous shunting from metastatic leiomyosarcoma

Annie Ngai Man Wong, Shankar Siva, Renee Manser, Richard Dowling, Phillip Antippa, Kwang Chin, Linda Rose Mileshkin

Journal article  |  2015  |  Journal of Medical Imaging and Radiation Oncology

The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup

David K Gaffney, Gita Suneja, Sang Young Ryu, Mary McCormick, Marie Plante, Linda Mileshkin, William Small, Monica Bacon, Gavin Stuart, Henry Kitchener

Journal article  |  2015  |  International Journal of Radiation Oncology*Biology*Physics

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

Ellen Stelloo, Tjalling Bosse, Remi A Nout, Helen J MacKay, David N Church, Hans W Nijman, Alexandra Leary, Richard J Edmondson, Melanie E Powell, Emma J Crosbie, Henry C Kitchener, Linda Mileshkin, Pamela M Pollock, Vincent T Smit, Carien L Creutzberg

Journal article  |  2015  |  Modern Pathology

Whole-genome characterization of chemoresistant ovarian cancer

Ann-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, Dale W Garsed, Joshy George, Sian Fereday, Katia Nones, Prue Cowin, Kathryn Alsop, Peter J Bailey, Karin S Kassahn, Felicity Newell, Michael CJ Quinn, Stephen Kazakoff, Kelly Quek, Charlotte Wilhelm-Benartzi, Ed Curry, Huei San Leong, Anne Hamilton, Linda Mileshkin, et al.

Journal article  |  2015  |  Nature

Geriatric assessment of older patients with cancer in Australia-A multicentre audit

Roopa Lakhanpal, Jaclyn Yoong, Sachin Joshi, Desmond Yip, Linda Mileshkin, Gavin M Marx, Tracey Dunlop, Elizabeth J Hovey, Stephen A Della Fiorentina, Lakshmi Venkateswaran, Martin HN Tattersall, Sem Liew, Kathryn Field, Nimit Singhal, Christopher B Steer

Journal article  |  2015  |  Journal of Geriatric Oncology

CARCINOMA OF UNKNOWN PRIMARY - RARE BUT RIPE FOR HELP FROM GENOMICS?

Lisa Guccione, Linda Mileshkin, Penelope Schofield, David Bowtell

Journal article  |  2015  |  Cancer Forum

Development and validation of a gene expression tumour classifier for cancer of unknown primary

Richard W Tothill, Fan Shi, Lisa Paiman, Justin Bedo, Adam Kowalczyk, Linda Mileshkin, Evangeline Buela, Robert Klupacs, David Bowtell, Keith Byron

Journal article  |  2015  |  Pathology

Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside

Jeremy Lewin, Carleen Cullinane, Tim Akhurst, Kelly Waldeck, D Neil Watkins, Aparna Rao, Peter Eu, Linda Mileshkin, Rodney J Hicks

Journal article  |  2015  |  European Journal of Nuclear Medicine and Molecular Imaging

Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.

Helen J Mackay, Lari Wenzel, Linda Mileshkin

Journal article  |  2015  |  American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Despite the declining incidence of cervical cancer as a result of the introduction of screening programs, globally it remains a le..

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Small Cell Carcinoma of the Cervix

Toyomi Satoh, Yuji Takei, Isabelle Treilleux, Mojgan Devouassoux-Shisheboran, Jonathan Ledermann, Akila N Viswanathan, Sven Mahner, Diane M Provencher, Linda Mileshkin, Elizabeth Avall-Lundqvist, Patricia Pautier, Nicholas Simon Reed, Keiichi Fujiwara

Journal article  |  2014  |  International Journal of Gynecologic Cancer

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian and Primary Peritoneal Low-Grade Serous Carcinomas

Charlie Gourley, John Farley, Diane M Provencher, Sandro Pignata, Linda Mileshkin, Philipp Harter, Johanna Maenpaa, Jae-Weon Kim, Eric Pujaide-Lauraine, Rosalind M Glasspool, Isabelle Ray-Coquard, David Gershenson

Journal article  |  2014  |  International Journal of Gynecologic Cancer

We should not settle for low-level evidence but should always use the best available evidence

Kailash Narayan, Linda Mileshkin, Sylvia van Dyk, David Bernshaw, Pearly Khaw, Srinivas Kondalsamy Chennakesavan

Journal article  |  2014  |  Journal of Gynecologic Oncology

The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intent

Chrishanthi Rajasooriyar, David Bernshaw, Srinivas Kondalsamy-Chennakesavan, Linda Mileshkin, Kailash Narayan

Journal article  |  2014  |  Journal of Gynecologic Oncology

Smokers With Cervix Cancer Have More Uterine Corpus Invasive Disease and an Increased Risk of Recurrence After Treatment With Chemoradiation

Linda Mileshkin, Ashvin Paramanathan, Srinivas Kondalsamy-Chennakesavan, David Bernshaw, Pearly Khaw, Kailash Narayan

Journal article  |  2014  |  International Journal of Gynecologic Cancer

Ultrasound guided conformal brachytherapy of cervix cancer: survival, patterns of failure, and late complications

Kailash Narayan, Sylvia van Dyk, David Bernshaw, Pearly Khaw, Linda Mileshkin, Srinivas Kondalsamy-Chennakesavan

Journal article  |  2014  |  Journal of Gynecologic Oncology

Acceptability of Early Integration of Palliative Care in Patients with Incurable Lung Cancer

Brian HC Le, Linda Mileshkin, Katie Doan, Di Saward, Odette Spruyt, Jaclyn Yoong, Dishan Gunawardana, Matthew Conron, Jennifer Philip

Journal article  |  2014  |  Journal of Palliative Medicine

Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)

George Au-Yeung, Penelope M Webb, Anna DeFazio, Sian Fereday, Mathias Bressel, Linda Mileshkin

Journal article  |  2014  |  Gynecologic Oncology

Psychiatric Morbidity in Patients With Lung Cancer Response

Damien Urban, Aparna Rao, Mathias Bressel, Dina Neiger, Benjamin Solomon, Linda Mileshkin

Journal article  |  2014  |  Chest

Pertuzumab and Erlotinib in Patients With Relapsed Non-Small Cell Lung Cancer: A Phase II Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging

Brett Hughes, Linda Mileshkin, Peter Townley, Barbara Gitlitz, Keith Eaton, Paul Mitchell, Rodney Hicks, Katie Wood, Lucas Amler, Bernard M Fine, David Loecke, Andrea Pirzkall

Journal article  |  2014  |  The Oncologist

Low physical activity levels and functional decline in individuals with lung cancer

Catherine L Granger, Christine F McDonald, Louis Irving, Ross A Clark, Karla Gough, Andrew Murnane, Linda Mileshkin, Meinir Krishnasamy, Linda Denehy

Journal article  |  2014  |  Lung Cancer

Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary

Richard W Tothill, Jason Li, Linda Mileshkin, Ken Doig, Terence Siganakis, Prue Cowin, Andrew Fellowes, Timothy Semple, Stephen Fox, Keith Byron, Adam Kowalczyk, David Thomas, Penelope Schofield, David D Bowtell

Journal article  |  2013  |  Journal of Pathology

Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1-Amplified Ovarian Cancer

Dariush Etemadmoghadam, George Au-Yeung, Meaghan Wall, Chris Mitchell, Maya Kansara, Elizabeth Loehrer, Crisoula Batzios, Joshy George, Sarah Ftouni, Barbara A Weir, Scott Carter, Irma Gresshoff, Linda Mileshkin, Danny Rischin, William C Hahn, Paul M Waring, Gad Getz, Carleen Cullinane, Lynda J Campbell, David D Bowtell

Journal article  |  2013  |  Clinical Cancer Research

Suicide in Lung Cancer Who Is at Risk?

Damien Urban, Aparna Rao, Mathias Bressel, Dina Neiger, Benjamin Solomon, Linda Mileshkin

Journal article  |  2013  |  Chest

Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities

D Urban, A Rao, M Bressel, YR Lawrence, L Mileshkin

Journal article  |  2013  |  British Journal of Cancer

Patients Treated With Platinum-Doublet Chemotherapy for Advanced Non-Small-Cell Lung Cancer Have Inferior Outcomes If Previously Treated With Platinum-based Chemoradiation

Ashvin Paramanathan, Benjamin Solomon, Marnie Collins, Michael Franco, Sarah Kofoed, Heather Francis, David Ball, Linda Mileshkin

Journal article  |  2013  |  Clinical Lung Cancer

Hemoglobin Level in Cervical Cancer A Surrogate for an Infiltrative Phenotype

Maroie Barkati, Israel Fortin, Linda Mileshkin, David Bernshaw, Jean-Francois Carrier, Kailash Narayan

Journal article  |  2013  |  International Journal of Gynecological Cancer

A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (Peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trial

Penelope Schofield, Ilona Juraskova, Rebecca Bergin, Karla Gough, Linda Mileshkin, Meinir Krishnasamy, Kate White, David Bernshaw, Sylvia Penberthy, Sanchia Aranda

Journal article  |  2013  |  Trials

Radiation with cisplatin or carboplatin for locally advanced cervix cancer: The experience of a tertiary cancer centre

George Au-Yeung, Linda Mileshkin, David M Bernshaw, Srinivas Kondalsamy-Chennakesavan, Danny Rischin, Kailash Narayan

Journal article  |  2013  |  Journal of Medical Imaging and Radiation Oncology

Early Cardiovascular Death in Patients with Cancer

Mark Voskoboynik, Damien Urban, Linda Mileshkin

Journal article  |  2012  |  New England Journal of Medicine

MEASURING THE FUNCTIONAL DECLINE OF PEOPLE WITH ADVANCED STAGE NON-SMALL CELL LUNG CANCER (NSCLC)

L Mileshkin, A Murnane, M Krishnasamy, K Gough, C Granger, L Denehy

Conference Proceedings  |  2012  |  JOURNAL OF THORACIC ONCOLOGY

PHYSICAL ACTIVITY LEVELS AND FUNCTIONAL CAPACITY OF PEOPLE WITH NON-SMALL CELL LUNG CANCER: PRELIMINARY RESULTS

CL Granger, CF McDonald, L Irving, R Clark, L Mileshkin, M Krishnasamy, A Murnane, L Denehy

Conference Proceedings  |  2012  |  JOURNAL OF THORACIC ONCOLOGY

LIMITING THE FUNCTIONAL DECLINE OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A HOME BASED EXERCISE PROGRAM (HEP)

A Murnane, M Krishnasamy, L Denehy, C Granger, L Mileshkin

Conference Proceedings  |  2012  |  JOURNAL OF THORACIC ONCOLOGY

Measuring the functional decline of people with advanced-stage non-small cell lung cancer (NSCLC).

Linda Denehy, Andrew Murnane, Meinir Krishnasamy, Karla Gough, Catherine Granger, Linda R Mileshkin

Conference Proceedings  |  2012  |  JOURNAL OF CLINICAL ONCOLOGY

Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors

Jeffrey R Infante, D Ross Camidge, Linda R Mileshkin, Eric X Chen, Rodney J Hicks, Danny Rischin, Howard Fingert, Kristen J Pierce, Huiping Xu, W Gregory Roberts, S Martin Shreeve, Howard A Burris, Lillian L Siu

Journal article  |  2012  |  Journal of Clinical Oncology

Stories of the music of hope

Linda R Mileshkin, Phillip Antippa, Penelope Schofield

Journal article  |  2012  |  Medical Journal of Australia

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

Ian Collins, Prudence Francis, Linda Mileshkin

Journal article  |  2012  |  New England Journal of Medicine

Prognostic Significance of Lymphovascular Space Invasion and Nodal Involvement in Intermediate- and High-Risk Endometrial Cancer Patients Treated With Curative Intent Using Surgery and Adjuvant Radiotherapy

Kailash Narayan, Pearly Khaw, David Bernshaw, Linda Mileshkin, Srinivas Kondalsamy-Chennakesavan

Journal article  |  2012  |  International Journal of Gynecological Cancer

Predictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside?

Linda Mileshkin, Bhaumik Shah, Michael Michael

Journal article  |  2012  |  Chemotherapy Research and Practice

There have been many exciting new breakthroughs in understanding tumour biology. This has opened up the possibility of personalize..

Access to expensive anti-cancer drugs.

Linda Mileshkin, Danny Sullivan

Journal article  |  2011  |  Journal of Law and Medicine

Expensive anti-cancer drugs expose controversy underlying the process for resource allocation decisions, and intermittently result..

Carboplatin Dosing in Ovarian Cancer Problems and Pitfalls

Ian M Collins, Rachel Roberts-Thomson, David Faulkner, Danny Rischin, Michael Friedlander, Linda Mileshkin

Journal article  |  2011  |  International Journal of Gynecological Cancer

What constitutes a multidisciplinary team meeting?

Linda Mileshkin, John Zalcberg

Journal article  |  2011  |  Asia-Pacific Journal of Clinical Oncology

Patients' understanding of clinical trials needs to be assessed in the context of understanding of overall goals of care

Jaclyn Yoong, Michael Jefford, Linda Mileshkin

Journal article  |  2011  |  Supportive Care in Cancer

The adjuvant management of endometrial cancer: A review of the role of systemic therapy

L Mileshkin, S Jamil

Journal article  |  2011  |  European Journal of Clinical and Medical Oncology

Changes in F-18-Fluorodeoxyglucose and F-18-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer Treated with Erlotinib

Linda Mileshkin, Rodney J Hicks, Brett GM Hughes, Paul LR Mitchell, Veena Charu, Barbara J Gitlitz, David Macfarlane, Benjamin Solomon, Lukas C Amler, Wei Yu, Andrea Pirzkall, Bernard M Fine

Journal article  |  2011  |  Clinical Cancer Research

Rational use of trastuzumab in metastatic and locally advanced breast cancer: Implications of recent research

Shorn Goel, Jacquie Chirgwin, Prudence Francis, Robin Stuart-Harris, Joanna Dewar, Linda Mileshkin, Ray Snyder, Michael Michael, Bogda Koczwara

Journal article  |  2011  |  The Breast Journal

Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer

David S Binns, Andrea Pirzkall, Wei Yu, Jason Callahan, Linda Mileshkin, Peter Conti, Andrew M Scott, David Macfarlane, Bernard M Fine, Rodney J Hicks

Journal article  |  2011  |  European Journal of Nuclear Medicine and Molecular Imaging

Satisfaction with the decision to participate in cancer clinical trials is high, but understanding is a problem

M Jefford, L Mileshkin, J Matthews, H Raunow, C O'Kane, T Cavicchiolo, H Brasier, M Anderson, J Reynolds

Journal article  |  2011  |  Supportive Care in Cancer

Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma

Andreas Obermair, Linda Mileshkin, Katharina Bolz, Srinivas Kondalsamy-Chennakesavan, Robyn Cheuk, Paul Vasey, David Wyld, Jeffrey Goh, James L Nicklin, Lewis C Perrin, Peter Sykes, Monika Janda

Journal article  |  2011  |  Gynecologic Oncology

An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009

S Lingaratnam, MA Slavin, L Mileshkin, B Solomon, K Burbury, JF Seymour, R Sharma, B Koczwara, SW Kirsa, ID Davis, M Prince, J Szer, C Underhill, O Morrissey, KA Thursky

Journal article  |  2011  |  Internal Medicine Journal

A cost analysis of febrile neutropenia management in Australia: ambulatory v. in-hospital treatment

Senthil Lingaratnam, Leon J Worth, Monica A Slavin, Craig A Bennett, Suzanne W Kirsa, John F Seymour, Andrew Dalton, Bogda Koczwara, H Miles Prince, Mary O'Reilly, Linda Mileshkin, Jeff Szer, Karin A Thursky

Journal article  |  2011  |  Australian Health Review

Use of antibacterial prophylaxis for patients with neutropenia

MA Slavin, S Lingaratnam, L Mileshkin, DL Booth, MJ Cain, DS Ritchie, A Wei, KA Thursky

Journal article  |  2011  |  Internal Medicine Journal

Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011

S Lingaratnam, MA Slavin, B Koczwara, JF Seymour, J Szer, C Underhill, M Prince, L Mileshkin, M O'Reilly, SW Kirsa, CA Bennett, ID Davis, O Morrissey, KA Thursky

Journal article  |  2011  |  Internal Medicine Journal

The practical challenges of recruitment and retention when providing psychotherapy to advanced breast cancer patients

Ann Boonzaier, Annabel Pollard, Maria Ftanou, Jeremy W Couper, Penelope Schofield, Linda Mileshkin, Michael Henderson

Journal article  |  2010  |  Supportive Care in Cancer

Does multidisciplinary care enhance the management of advanced breast cancer?: evaluation of advanced breast cancer multidisciplinary team meetings.

Jacquie Chirgwin, Melinda Craike, Christine Gray, Kathy Watty, Linda Mileshkin, Patricia M Livingston

Journal article  |  2010  |  Journal of Oncology Practice

PURPOSE: To assess the contribution of the advanced breast cancer (ABC) multidisciplinary team meetings (MDMs) to patient care and..

What Should a Support Program for People with Lung Cancer Look Like? Differing Attitudes of Patients and Support Group Facilitators

Bianca Devitt, Allison Hatton, Carl Baravelli, Penelope Schofield, Michael Jefford, Linda Mileshkin

Journal article  |  2010  |  Journal of Thoracic Oncology

Phase 1 Study of Tirapazamine in Combination With Radiation and Weekly Cisplatin in Patients With Locally Advanced Cervical Cancer

Danny Rischin, Kailash Narayan, Amit M Oza, Linda Mileshkin, David Bernshaw, Jimin Choi, Rodney Hicks, Bev McClure, Anthony Fyles

Journal article  |  2010  |  International Journal of Gynecological Cancer

To Tell or Not to Tell: The Community Wants to Know About Expensive Anticancer Drugs As a Potential Treatment Option

Linda Mileshkin, Penelope E Schofield, Michael Jefford, Emilia Agalianos, Michele Levine, Alan Herschtal, Julian Savulescu, Jacqui Ann Thomson, John R Zalcberg

Journal article  |  2009  |  Journal of Clinical Oncology

Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment

M Dickinson, HM Prince, S Kirsa, A Zannettino, SDJ Gibbs, L Mileshkin, J O'Grady, JF Seymour, J Szer, N Horvath, DE Joshua

Journal article  |  2009  |  INTERNAL MEDICINE JOURNAL

The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum

Jennifer A Westwood, William K Murray, Melanie Trivett, Nicole M Haynes, Benjamin Solomon, Linda Mileshkin, David Ball, Michael Michael, Angela Burman, Preethi Mayura-Guru, Joseph A Trapani, Stefan Peinert, Dirk Honemann, H Miles Prince, Andrew M Scott, Mark J Smyth, Phillip K Darcy, Michael H Kershaw

Journal article  |  2009  |  Journal of Immunotherapy

Discussing Expensive Anticancer Drugs

Michael Jefford, Linda Mileshkin, Penelope Schofield, Emilia Agalianos, Jacqui Thomson, John Zalcberg

Journal article  |  2009  |  Journal of Clinical Oncology

Predicting durable remissions following thalidomide therapy for relapsed myeloma

Hang Quach, Linda Mileshkin, John F Seymour, Alvin Milner, David Ritchie, Simon Harrison, David Westerman, H Miles Prince

Journal article  |  2009  |  Leukemia and Lymphoma

Lung cancer: challenges and solutions for supportive care intervention research.

Penelope Schofield, Anna Ugalde, Mariko Carey, Linda Mileshkin, Mary Duffy, David Ball, Sanchia Aranda

Journal article  |  2008  |  Palliative & Supportive Care

Lung cancer is the leading cause of cancer death. It is associated with a high level of morbidity, particularly fatigue, pain, bre..

In vivo tracking of dendritic cells in patients with multiple myeloma

H Miles Prince, Dominic M Wall, David Ritchie, Dirk Honemann, Simon Harrrison, Hang Quach, Mick Thompson, Rodney Hicks, Eddie Lau, Jill Davison, Maureen Loudovaris, Jude Moloney, Bruce Loveland, Jacques Bartholeyns, Andrew Katsifis, Linda Mileshkin

Journal article  |  2008  |  Journal of Immunotherapy

Synchronous diagnosis of Hodgkin lymphoma and osteosarcoma

A Fon, L Mileshkin, J Slavin, H Twomey, P James, DM Thomas

Journal article  |  2007  |  Internal Medicine Journal

Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines, angiogenic markers, mast cells and marrow CD57( ) cytotoxic T cells as predictors of outcome

Linda Mileshkin, Dirk Honemann, Peter Gambell, Melanie Trivett, Yoshihiro Hayakawa, Mark Smyth, Victoria Beshay, David Ritchie, Paul Simmons, Alvin D Milner, Jerome B Zeldis, H Miles Prince

Journal article  |  2007  |  Haematologica

Tailored chemotherapy (CT) information (info) faxed to general practitioners (GP) improves knowledge and confidence in managing side effects (SFX): Results from a randomized controlled trial (RCT)

MH Jefford, C Baravelli, A Dabscheck, M Evans, M Moloney, P Schofield

Journal article  |  2007  |  Journal of Clinical Oncology

Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: a study of bortezomib and thalidomide

HM Prince, B Schenkel, L Mileshkin

Journal article  |  2007  |  Leukemia

In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma

D Ritchie, L Mileshkin, D Wall, J Bartholeyns, M Thompson, J Coverdale, E Lau, J Wong, P Eu, RJ Hicks, HM Prince

Journal article  |  2007  |  Cancer Immunology, Immunotherapy

An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myeloma

H Miles Prince, Brad Schenkel, Linda Mileshkin

Journal article  |  2007  |  Leukemia and Lymphoma

Treatment strategies in elderly patients with multiple myeloma: current status.

Hang Quach, H Miles Prince, Linda Mileshkin

Journal article  |  2007  |  Drugs and Aging

Multiple myeloma (MM), a plasma cell malignancy, is a disorder of the elderly with an increasing prevalence as the average life ex..

The troublesome toxicity of peripheral neuropathy with thalidomide

Linda Mileshkin, H Miles Prince

Journal article  |  2006  |  Leukemia & Lymphoma

Development of neuropathy in patients with myeloma treated with thalidomide: Patterns of occurrence and the role of electrophysiologic monitoring

Linda Mileshkin, Richard Stark, Bruce Day, John F Seymour, Jerome B Zeldis, H Miles Prince

Journal article  |  2006  |  Journal of Clinical Oncology

The multidisciplinary management of patients with cancer

L Mileshkin, J Zalcberg

Journal article  |  2006  |  Annals of Oncology

Do oncologists discuss expensive anti-cancer drugs with their patients?

J Thomson, P Schofield, L Mileshkin, E Agalianos, J Savulescu, J Zalcberg, M Jefford

Journal article  |  2006  |  Annals of Oncology

A multicenter phase II trial of thalidomide and celecoxib for patients with relapsed and refractory multiple myeloma

HM Prince, L Mileshkin, A Roberts, V Ganju, C Underhill, J Catalano, R Bell, JF Seymour, D Westerman, PJ Simmons, K Lillie, AD Milner, J Di Iulio, JB Zeldis, R Ramsay

Journal article  |  2005  |  Clinical Cancer Research

The adverse prognostic impact of advanced age in multiple myeloma

L Mileshkin, HM Prince

Journal article  |  2005  |  Leukemia & Lymphoma

An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

LJ Worth, MJ Dooley, JF Seymour, L Mileshkin, MA Slavin, KA Thursky

Journal article  |  2005  |  British Journal of Cancer

Management of Complications of Chemotherapy

L Mileshkin, Y Antill, D Rischin

Book Chapter  |  2004

CNS listeriosis confused with leptomeningeal carcinomatosis in a patient with a malignant insulinoma

L Mileshkin, M Michael, M O'Reilly, A McKenzie, R Stark

Journal article  |  2002  |  American Journal of Clinical Oncology

Gemcitabine for patients with relapsed nasopharyngeal carcinoma

L Mileshkin, D Rischin

Journal article  |  2002  |  Internal Medicine Journal

Successful treatment of rhinocerebral zygomycosis using liposomal nystatin

L Mileshkin, M Slavin, JF Seymour, A McKenzie

Journal article  |  2001  |  Leukemia & Lymphoma